66
Views
1
CrossRef citations to date
0
Altmetric
Miscellany

Doxycycline Revisited: Proceedings of a Symposium Held in New York, NY, 9 October 1987

Pages 1-79 | Published online: 02 Jan 2015

References

  • Drug dose statistics. Norsk Medisinaldepot (ed.), Oslo, Norway 1974
  • Kilian M. A rapid method for the differentiation of Haemophilus strains. The porphyrin test. Acta Pathol Microbiol Scand (B) 82: 835–842, 1974
  • Ericsson HM, Sherris JC. Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol Microbiol Scand (B), Suppl 217: 1–90, 1971
  • The Swedish Reference Group for Antibiotics. A revised system for antibiotic sensitivity testing. Scand J Infect Dis 13: 148–152, 1981
  • O'Callaghan CH, Morris A, Kirby SM, Shingler AH. Novel method for the detection of beta-lactamase by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother 1: 283–288, 1972
  • Zackrisson G, Brorson J-E. Antibiotic sensitivity of Haemophilus influenzae strains including three recent chloramphenicol-resistant isolates. Acta Pathol Microbiol Scand (B) 88: 193–198, 1980
  • Forsgren A, Walder M. Haemophilus influenzae, pneumococci, group A streptococci and Staphylococcus aureus: Sensitivity of outpatient strains to commonly prescribed antibiotics. Scand J Infect Dis 14: 39–43, 1982
  • Kallings I, Bengtsson S, Christensen P, Holm SE, Lind L, Kalin M. Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden. Scand J Infect Dis, Suppl 39: 100–105, 1983
  • Forsgren A, Walder M. Activity of common antibiotics against Branhamella catarrhalis, Haemophilus influenzae, pneumococci, group A streptococci and Staphylococcus aureus in 1983. Acta Otolaryngol (Stockh), Suppl 407: 43–49, 1984
  • Minuth JN, Holmes TM, Musher DM. Activity of tetracycline, doxycycline, and minocycline against meticillin-susceptible and -resistant staphylococci. Antimicrob Agents Chemother 6: 411–414, 1974
  • Wood MJ, Farrell W, Kattan S, Williams JD. Activity of minocycline and tetracycline against respiratory pathogens related to blood levels. J Antimicrob Chemother 1: 323–331, 1975
  • Powell M, Koutsia-Carouzou C, Voutsinas D, Seymour A, Williams JD. Resistance of clinical isolates of Haemophilus influenzae in United Kingdom 1986. Br Med J 295: 176–179, 1987
  • Doern GV, Jorgensen JH, Thornsberry C, Preston DA, and the Haemophilus influenzae Surveillance Group. Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: A collaborative study. Diagn Microbiol Infect Dis 4: 95–107, 1986

References

  • Niitu Y, Hasegawa S, Suetake T, Kubota H, Komatsu S, Horikawa M. Resistance of Mycoplasma pneumoniae to erythromycin and other antibiotics. J Pediatr 76: 438–443, 1970
  • Niitu Y, Hasegawa S, Kubota H. In vitro development of resistance to erythromycin, other macrolide antibiotics, and lincomycin in Mycoplasma pneumoniae. Antimicrob Agents Chemother 5: 513–519, 1974
  • Stopler T, Gerichter CB, Branski D. Antibiotic-resistant mutants of Mycoplasma pneumoniae. Isr J Med Sci 16: 169–173, 1980
  • Hjelm E, Jonsell G, Linglöf T, Mårdh P-A, Møller B, Sedin G. Meningitis in a newborn infant caused by Mycoplasma hominis. Acta Paediatr Scand 69: 415–418, 1980
  • Koutsky LA, Stamm WE, Brunham RC, Stevens CE, Cole B, Hale J, Davick P, Holmes KK. Persistence of Mycoplasma hominis after therapy: Importance of tetracycline resistance and of coexisting vaginal flora. Sex Transm Dis 11 Suppl: 374–381, 1983
  • Bebear C, Cantet P, Renaudin H, Quentin C. Activité comparée de la minocycline et doxycycline sur les mycoplasmes pathogènes pour l'homme. Pathol Biol (Paris) 33: 577–580, 1985
  • Spaepen MS, Kundsin RB. Simple, direct broth-disk method for antibiotic susceptibility testing of ureaplasma urealyticum. Antimicrob Agents Chemother 11: 267–270, 1977
  • Evans RT, Taylor-Robinson D. The incidence of tetracyline-resistant strains of ureaplasma urealyticum. J Antimicrob Chemother 4: 57–63, 1978
  • Robertson JA, Coppola JE, Heisler OR. Standardized method for determining antimicrobial susceptibility of strains of ureaplasma urealyticum and their response to tetracycline, erythromycin and rosaramicin. Antimicrob Agents Chemother 20: 53–58, 1981
  • Davis JW, Hanna BA. Antimicrobial susceptibility of ureaplasma urealyticum. J Clin Microbiol 13: 320–325, 1981
  • Del Giudice RA, Pavia R. Hemadsorption by Mycoplasma pneumoniae and its inhibition with sera from patients with atypical pneumonia. Bacteriol Proc, p. 71, 1964
  • Manchee RJ, Taylor-Robinson D. Haemadsorption and haemagglutination by mycoplasmas. J Gen Microbiol 50: 465–478, 1968
  • Clyde WA Jr. Mycoplasma species identification based upon growth inhibition by specific antisera. J Immunol 92: 958–965, 1964
  • Clyde WA Jr. Serological identification of mycoplasmas from humans. In: Tully JG, Razin S, eds. Methods in mycoplasmology, vol. 2, New York: Academic Press, 37–45, 1983
  • Rosendal S, Black FT. Direct and indirect immunofluorescence of unfixed and fixed mycoplasma colonies. Acta Pathol Microbiol Scand Sect B 80: 615–622, 1972
  • Shepard MC, Lunceford CD. Differential agar medium (A7) for identification of Ureaplasma urealyticum (human T mycoplasmas) in primary cultures of clinical material. J Clin Microbiol 3: 613–625, 1976
  • Tully JG, Whitcomb RF, Clark HF, Williamson DL. Pathogenic mycoplasmas: Cultivation and vertebrate pathogenicity of a new spiroplasma. Science 195: 892–894, 1977
  • Shepard MC, Howard DR. Identification of “T” mycoplasmas in primary agar cultures by means of a direct test for urease. Ann NY Acad Sci 174: 809–819, 1970
  • Purcell RH, Taylor-Robinson D, Wong D, Chanock RM. Color test for the measurement of antibody to T-strain mycoplasmas. J Bacteriol 92: 6–12, 1966
  • Jao RL, Finland M. Susceptibility of Mycoplasma pneumoniae to 21 antibiotics in vitro. Am J Med Sci 253: 639–650, 1967
  • Mårdh P-A. Human respiratory tract infections with mycoplasmas and their in vitro susceptibility to tetracyclines and some other antibiotics. Chemotherapy (Basel) 21 Suppl 1: 47–57, 1975
  • Weström L, Mårdh P-A. The effect of antibiotic therapy on mycoplasma in the female genital tract. Acta Obstet Gynecol Scand 50: 25–31, 1971
  • Spaepen MS, Kundsin RB, Horne HW. Tetracycline-resistant T-mycoplasmas (Ureaplasma urealyticum) from patients with a history of reproductive failure. Antimicrob Agents Chemother 9: 1012–1018, 1976
  • Eliasson R, Malmborg A-S. Concentrations of doxycycline in human seminal plasma. Scand J Infect Dis, Suppl 9: 32–36, 1976
  • Belli G, Ciaffi G, Ricci P. Blood and tissue levels of two antibiotics of the tetracycline group orally administered to man. Antibiotica 6: 109–115, 1968
  • Lutziger H. Konzentrationsbestimmungen und klinische Wirksamkeit von Doxycycline (Vibramycin) in Uterus, Adnexen und Muttermilch. Ther Umsch 26: 476–480, 1969
  • Brihmer C, Olson Liljequist B, Brundin J. Levels of erythromycin in human oviduct mucosa and serum. IRCS Medical Science 14: 1114–1115, 1986

References

  • Blanchard P, Rudhardt M, Fabre J. Behaviour of doxycycline in the tissues. Chemotherapy (Basel) 21, Suppl 1: 8–18, 1975
  • Brown KN, Percival A. Penetration of antimicrobials into tissue culture cells and leucocytes. Scand J Infect Dis, Suppl 14: 251–260, 1978
  • Forsgren A, Bellahsène A. Antibiotic accumulation in human polymorphonuclear leucocytes and lymphocytes. Scand J Infect Dis, Suppl 44: 16–23, 1985
  • Dressler J, Mach P. A study of in vitro incorporation of tetracycline antibiotics into avian and mammalian blood cells. Folia Haematol 84: 368, 1965
  • Cars O, Ryan DM. Determination of extravascular concentrations of doxycycline. J Antimicrob Chemother 12: 277–279, 1983
  • Cars O, Ögren S. A microtechnique for determination of antibiotics in muscle. J Antimicrob Chemother 8: 39–48, 1981
  • Cars O. Tissue distribution of ampicillin: Assays in muscle tissue and subcutaneous tissue cage fluid from normal and nephrectomized rabbits. Scand J Infect Dis 13: 283–289, 1981
  • Nelis Hjcf, De Leenheer AP. Liquid chromatographic estimation of doxycycline in human tissues. Clin Chem Acta 103: 209–217, 1980
  • Cunhua BA, Sibley CM, Ristuccia AM. Doxycycline. Ther Drug Monitor 4: 115–135, 1982
  • Schach von Wittenau M, Delahunt CS. The distribution of tetracyclines in tissues of dogs after repeated oral administration. J Pharmacol Exp Ther 152: 164–169, 1966
  • Cars O, Ögren S. Antibiotic tissue concentrations: Methodological aspects and interpretation of results. Scand J Infect Dis, Suppl 44: 7–15, 1985
  • Ryan DM, Cars O. A problem in the interpretation of β-lactam antibiotic levels in tissues. J Antimicrob Chemother 12: 281–284, 1983
  • Ryan DM, Cars O, Hoffstedt B. The use of antibiotic serum levels to predict concentrations in tissues. Scand J Infect Dis 18: 381–388, 1986
  • Schach von Wittenau M, Yeary R. The excretion and distribution in body fluids of tetracyclines after intravenous administration to dogs. J Pharmacol Exp Ther 140: 258–266, 1963
  • Andersson KE, Dencker H, Mårdh PA, Åkerlund M. Relationships between the concentrations of doxycycline in serum and in thoracic duct lymph after oral and intravenous administration in man. Chemotherapy (Basel) 22: 277–285, 1976
  • Lundberg C, Gullers C, Malmborg AS. Antibiotics in sinus secretions. Lancet ii: 107–108, 1968

References

  • Chodosh S. Comparison of bacampicillin twice daily and ampicillin four times daily in treatment of acute exacerbations of chronic bronchitis. Rev Infect Dis 3: 140–149, 1981
  • Chodosh S, Eichel B, Ellis C, Medici TC. Comparison of trimethoprim-sulfamethoxazole with ampicillin in acute infectious exacerbations of chronic bronchitis: A double-blind crossover study. Rev Infect Dis 4: 517–527, 1982
  • Medici TC, Chodosh S. Non-malignant sputum cytology. In: Dulfano MJ, ed.Sputum. Springfield, Ill.: Charles C Thomas, 332–381, 1973
  • Baigelman W, Chodosh S, Pizzuto D, Sadow T. Quantitative sputum gram stains in chronic bronchial disease. Lung 156: 265–270, 1979
  • Chodosh S, Medici TC. The bronchial epithelium in chronic bronchitis. I. Exfoliative cytology during stable, acute bacterial infection and recovery phases. Am Rev Resp Dis 104: 888–898, 1971
  • Chodosh S. A comparison of doxycycline and cefaclor in acute bacterial exacerbations of chronic bronchial disease. Internal Medicine for the Specialist. Suppl: 24–38, 1983
  • Chodosh S. Sputum cytology in chronic bronchial disease. Advances in Asthma and Allergy 4: 8–27, 1977
  • Chodosh S. Acute bacterial exacerbations in bronchitis and asthma. Am J Med 82 ( Suppl 4A): 154–163, 1987
  • Chodosh S. Sputum: Observations in status asthmaticus and therapeutic considerations. In: Weiss EB, ed.Status asthmaticus. Baltimore: University Park Press, 173–200, 1978
  • Faling LJ, Medici TC, Chodosh S. Sputum cell population measurements in brochial injury: Observations in acute smoke inhalation. Chest 65 ( Suppl): 56S–59S, 1974
  • Tager I, Speizer FE. Role of infection in chronic bronchitis. N Engl J Med 292: 563–571, 1975

References

  • Martini N, Bains MS, Beattie EJ Jr. Indications for pleurectomy in malignant effusion. Cancer 35: 734–738, 1975
  • Strober SJ, Klotz E, Kuperman A, Ghossein NA. Malignant pleural disease—a radiotherapeutic approach to the problem. JAMA 226: 296–299, 1973
  • Andersson CB, Philpott GW, Ferguson TB. The treatment of malignant pleural effusions. Cancer 33: 916–922, 1974
  • Izbicki R, Weyling BT, Baker L, Caoili EM, Vaitkwicius VK. Pleural effusion in cancer patients: A prospective randomized study of pleural drainage with the addition of radioactive phosphorous to the pleural space vs. pleural drainage alone. Cancer 36: 1511–1518, 1975
  • Adler RM, Sayek I. Treatment of malignant pleural effusion: A method using tube thoracostomy and talc. Ann Thorac Surg 22: 8–15, 1976
  • McLeod DT, Calverley PMA, Millar JW, Horne NW. Further experience of Corynebacterium parvum in malignant pleural effusion. Thorax 40: 515–518, 1985
  • Gellhorn A, Zaidenweber J, Ultman J, Hierschberg E. The use of Atabrine (Quinacrine) in the control of recurrent neoplastic effusions. Dis Chest 39: 165–175, 1961
  • Stiksa G, Korsgaard R, Simonsson BG. Treatment of recurrent pleural effusion by pleurodesis with quinacrine. Scand J Resp Dis 60: 197–205, 1979
  • Engel GL. Quinacrine effects on the central nervous system. JAMA: 197: 515, 1966
  • Borda I, Krant M. Convulsions following intrapleural administration of quinacrine hydrochloride. JAMA 201: 1049–1050, 1967
  • Bayly TC, Kisner DL, Sybert A, Macdonald JS, Tsou E, Schein PS. Tetracycline and quinacrine in the control of malignant effusions. Cancer 41: 1188–1192, 1978
  • Austin EH, Flye MW. The treatment of recurrent malignant pleural effusion. Ann Thorac Surg 28: 190–203, 1979
  • Sørensen PG, Svendsen TL, Enk B. Treatment of malignant pleural effusions with drainage, with and without instillation of talc. Eur J Respir Dis 65: 131–135, 1984
  • Fracchia AA, Knapper WH, Carey JT, Farrow JH. Intrapleural chemotherapy for effusion from metastatic breast carcinoma. Cancer 26: 626–629, 1970
  • Thorsrud GK. Pleural reaction to irritants—an experimental study with special references to pleural adhesions and concrescence in relation to pleural turnover of fluid. Acta Chir Scand (Suppl) 355: 1–74, 1965
  • Rubinson RM, Bolooki H. Intrapleural tetracycline for control of malignant pleural effusion: A preliminary report. South Med J 65: 847–849, 1972
  • Wallach HW. Intrapleural tetracycline for malignant pleural effusion. Chest 68: 510–512, 1975
  • Zaloznik AJ, Oswald S, Langin M. Intrapleural tetracycline in malignant pleural effusions. Cancer 51: 752–755, 1983
  • Gravelyn TR, Michelson MK, Gross BH, Sitrin RG. Tetracycline pleurodesis for malignant pleural effusions. A 10-year retrospective study. Cancer 59: 1973–1977, 1987
  • Kitamura S, Sugiyama Y, Izumi T, Hayashi R, Kosaka K. Intrapleural doxycycline for control of malignant pleural effusion. Curr Ther Res 4: 515–521, 1981
  • Sahn SS, Potts DE. The effect of tetracycline on rabbit pleura. Am Rev Respir Dis 117: 493–499, 1978
  • Homma T, Yoneda S, Komuro Y, Yoshida S, Min KY, Takayama S. Pharmacokinetics and pleural reaction of doxycycline after intrapleural administration. Gan To Kagaku Ryoho 10: 1129–1134, 1983 (abstr. in English).
  • Antony VB, Owen CL, Sahn SA. Mechanism of tetracycline induced pleural fibrosis: Tetracycline stimulates fibroblast proliferation in vivo and in vitro. Am Rev Respir Dis 131: ( Suppl. A33), 1985
  • Antony VB, Owen CL, Sahn SA. Oxygen radical mediated pleural inflammation and fibrosis: An in vivo model. Am Rev Respir Dis 129: ( Suppl. A14), 1984
  • Wiedeman HP, Gee JBL, Lewbuga-MuRasa J. Mesothelial cell derived soluble factor stimulates fibroblast DNA synthesis (abstract). Am Rev Respir Dis 127: ( Suppl. A279), 1983
  • Sahn SA. Malignant pleural effusions. Clinics of chest medicine 6: 113–125, 1985

References

  • Slots J. Bacterial specificity in adult periodontitis. J Clin Periodontol 13: 912–917, 1986
  • Slots J, Reynolds HS, Genco RJ. Actinobacillus actinomycetemcomitans in human periodontal disease: A crossectional microbiological investigation. Infect Immun 29: 1013–1020, 1980
  • Mandell RL, Socransky SS. A selective medium for Actinobacillus actinomycetemcomitans and the incidence of the organism in juvenile periodontitis. J Periodontol 52: 593–598, 1981
  • Slots J, Evans RT, Lobbins PM, Genco RJ. In vitro antimicrobial susceptibility of Actinobacillus actinomycetemcomitans. Antimicrob Agents Chemother 18: 9–12, 1980
  • Sutter VL, Jones MJ, Ghoneim ATM. Antimicrobial susceptibilities of bacteria associated with periodontal disease. Antimicrob Agents Chemother 23: 483–486, 1983
  • Baker PJ, Evans RT, Slots J, Genco RJ. Susceptibility of human oral anaerobic bacteria to antibiotics suitable for topical use. J Clin Periodontol 12: 201–208, 1985
  • Walker CB, Gordon JM, Socransky SS. Antibiotic susceptibility testing of subgingival plaque samples. J Clin Periodontol 10: 422–432, 1983
  • Walker CB, Gordon JM, Cornwall HA, Murphy JC, Socransky SS. Gingival crevicular fluid levels of clindamycin compared with its minimal inhibitory concentrations for periodontal bacteria. Antimicrob Agents Chemother 19: 867–871, 1981
  • Heimdahl A, Nord CE. Effect of phenoxymethylpenicillin and clindamycin on the oral, throat and faecal microflora of man. Scand J Infect Dis 11: 233–242, 1979
  • Pascale D, Gordon J, Lamster I, Mann P, Seiger M, Arndt W. Concentration of doxycycline in human gingival fluid. J Clin Periodontol 13: 841–844, 1986
  • Heimdahl A, Nord CE. Influence of doxycycline on the normal human flora and colonization of the oral cavity and colon. Scand J Infect Dis 15: 293–302, 1983
  • Heimdahl A, Kager L, Nord CE. Changes in the oropharyngeal and colon microflora in relation to antimicrobial concentrations in saliva and faeces. Scand J Infect Dis 44: 52–58, 1985
  • Notten F, Koek-van Oosten A, Mikx F. Capillary agar diffusion assay for measuring metronidazole in human crevicular fluid. Antimicrob Agents Chemother 21: 836–837, 1982
  • Gordon JM, Walker CB, Goodson JM, Socransky SS. Sensitive assay for measuring tetracycline levels in gingival crevice fluid. Antimicrob Agents Chemother 17: 193–198, 1980
  • Nord CE, Kager L, Heimdahl A. Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections. Am J Med 76: 99–106, 1984
  • Heimdahl A, Nord CE. Effect of erythromycin and clindamycin on the indigenous human anaerobic flora and new colonization of the gastrointestinal tract. Eur J Clin Microbiol 1: 38–48, 1982
  • Heimdahl A, von Konow L, Nord CE. Clinical significance of penicillin-resistant betalactamase producing Bacteroides species in human orofacial infections. In: Betalaktamasen. Ullman U, ed. Stuttgart, Germany: Gustav Fisher Verlag, 49–56, 1983
  • Bystedt H, Heimdahl A, Nord CE. Prophylaxis with tinidazole in oral surgery—tissue penetration and effect on the oral microflora. Int J Oral Surg 13: 200–205, 1984
  • Listgarten MA, Lindhe J, Helldén LB. Effect of tetracycline and/or scaling on human periodontal disease. Clinical microbiological and histological observations. J Clin Periodontol 5: 246–271, 1978
  • Helldén LB, Listgarten MA, Lindhe J. The effect of tetracycline and/or scaling on human periodontal disease. J Clin Periodontol 6: 222–230, 1979
  • Slots J, Mashimo P, Levine MJ, Genco RJ. Periodontal therapy in humans. 1. Microbiological and clinical effects of a single course of periodontal scaling and root planing as an adjunct to tetracycline. J Periodontol 50: 495–509, 1979
  • Scopp JW, Froum SJ, Sullivan M, Kazandijian G, Wank D, Fine A. Tetracycline: A clinical study to determine its effectiveness as long-term adjuvant. J Periodont Res 5: 328–330, 1980
  • Genco RJ, Cianciola LJ, Resling B. Treatment of localized juvenile periodontitis. J Dent Res 60: 527, Abstract No 872, 1981
  • Kornman KS, Karl EH. The effect of long-term low dose tetracycline therapy on the sub-gingival microflora in refractory adult periodontitis. J Periodontol 53: 604610, 1982
  • Lindhe J. Treatment of localized juvenile periodontitis. In: Genco RJ, Mergenhagen SE, eds. Host-parasite interactions in periodontal disease. Washington D.C.: American Society for Microbiology, 382–394, 1982
  • Lindhe J, Liljenberg B, Adielsson B. Effect of longterm tetracycline therapy on human periodontal disease. J Clin Periodontol 10: 590–601, 1983
  • Slots J, Rosling BG. Suppression of the periodontopathic microflora in localized juvenile periodontitis by systemic tetracycline. J Clin Periodontol 48 : 497–504, 1983
  • Ciancio SG, Mather ML, McMullen JA. An evaluation of minocycline in patients with periodontal disease. J Periodontol 51: 531–533, 1980
  • Ciancio SG, Slots J, Reynolds H, Zambon JJ, McKenna J. The effect of short-term administration of minocycline HCl on gingival inflammation and subgingival microflora. J Periodontol 53: 557–561, 1982
  • Lundström A, Johansson LK, Hamp SE. Effect of combined systemic antimicrobial therapy and mechanical plaque control in patients with recurrent periodontal disease. J Clin Periodontol 11: 321–330, 1984
  • Mills WH, Thompson GW, Beagrie GS. Clinical evaluation of spiramycin and erythromycin in control of periodontal disease. J Clin Periodontol 6: 308–316, 1979
  • Gordon J, Walker C, Lamster J, West T, Socransky S, Seiger M, Fasciano R. Efficacy of clindamycin hydrochloride in refractory periodontitis. J Periodontol 56 ( Suppl 11): 75–80, 1985
  • Kunihara DM, Caine FA, Palcanis KG, Best AM, Ranney RR. A clinical trial of phenoxymethylpenicillin for adjunctive treatment of juvenile periodontitis. J Periodontol 56: 352–358, 1985
  • Loesche WJ, Syed AA, Morrison EC, Langhon B, Grassman NS. Treatment of periodontal infections due to anaerobic bacteria with short-term treatment with metronidazole. J Clin Periodontol 8: 29–44, 1981
  • Lindhe J, Liljenberg B, Adielsson B, Börjesson J. Use of metronidazole as a probe in the study of human periodontal disease. J Clin Periodontol 10: 100–112, 1983
  • Clark DC, Shenker S, Stulginsky P, Schwartz S. Effectiveness of routine periodontal treatment with and without adjunctive metronidazole therapy in a sample of mentally retarded adolescents. J Periodontol 54: 658–665, 1983
  • Walsh MM, Buchanan SA, Hoover CI, Newbrun E, Taggart EJ, Armitage GC, Robertson PB. Clinical and microbiological effects of single-dose metronidazole or scaling and root planing in treatment of adult periodontitis. J Clin Periodontol 13: 151–157, 1986
  • Loesche WJ, Syed SA, Morrison EC, Kerry GA, Higgins T, Stoll J. Metronidazole in periodontitis. J Periodontol 55: 325–335, 1984
  • Giedrys-Leeper E, Seleipsky H, Williams BL. Effect of short-term administration of metronidazole on the subgingival microflora. J Clin Periodontol 12: 797–814, 1985
  • Watts T, Palmer R, Floyd P. Metronidazole: A double-blind trial in untreated human periodontal disease. J Clin Periodontol 13: 939–943, 1986
  • Joyston-Bechal S, Smales FC, Duckworth R. Effect of metronidazole on chronic periodontal disease in subjects using a topically applied chlorhexidine gel. J Clin Periodontol 11: 53–62, 1984
  • Joyston-Bechal S, Smales FC, Duckworth A. Follow-up study 3 years after metronidazole therapy for chronic periodontal disease. J Clin Periodontol 13: 944–949, 1986
  • Mahmood MM, Dolby AE. The value of systemically administered metronidazole in the modified Widman flap procedure. J Periodontol 58: 147–152, 1987

References

  • Prien EL, Frandel C. Studies in urolithiasis 1. The composition of urinary calculi. J Urol 57: 949–991, 1947
  • Blandy JP, Singh M. The case for a more aggressive approach to staghorn stones. J Urol 115: 505–506, 1976
  • Griffith DP. Struvite stones. Kidney Int 13: 372–382, 1978
  • Thompson RB, Stamey TA. Bacteriology in infection stones. Urol 2: 627–633, 1973
  • Lewi HJE, White A, Hutchinson AG, Scott R. The bacteriology of the urine and renal calculi. Urol Res 12: 107–109, 1984
  • Mårdh, PA, Weström L, Collen S. Infections of the genital and urinary tracts with Mycoplasmas and Ureaplasmas. In Danielsson D, Juhlin L, Mårdh PA, eds. Proceedings of the symposium on genital infections and their complications. Stockholm: Almqvist & Wiksell, pp. 53–62, 1975
  • Grenabo L, Brorson JE, Hedelin H, Pettersson S. Ureaplasma urealyticum-induced crystallization of magnesium ammonium phosphate and calcium phosphates in synthetic urine. J Urol 132: 795–799, 1984
  • Takebe S, Numata A, Kobashi K. Stone formation by Ureaplasma urealyticum in human urine and its prevention by urease inhibitors. J Clin Microbiol 20: 869–823, 1984
  • Friedlander AM, Braude AI. Production of bladder stones by human T-mycoplasmas. Nature 247: 67–69, 1974
  • Grenabo, L, Brorson JE, Hedelin H, Pettersson S. Concrement formation in the urinary bladder in rats inoculated with Ureaplasma urealyticum. Urol Res 13: 195–198, 1985
  • Parsons CL, Greenspan C, Moore SW, Mulholland SG. Role of surface mucin in primary antibacterial defence of bladder. Urology 9: 48–52, 1977
  • Grenabo L, Hedelin H, Pettersson S. Adherence of urease-induced crystals to rat bladder epithelium. Urol Res 16: 49–52, 1988
  • Hedelin H, Brorson JE, Grenabo L, Pettersson S. Ureaplasma urealyticum and upper urinary tract stones. Br J Urol 56: 244–249, 1984
  • Grenabo L, Claes G, Hedelin H, Pettersson S. Rapidly recurrent renal stones caused by Ureaplasma urealyticum. A case report. J Urol 135: 416–419, 1986
  • Shepard MC, Lunceford CD. Urease color test medium U-9 for the detection and identification of “T” mycoplasmas in clinical material. Suppl Microbiol 20: 539–543, 1970
  • Yajko DM, Balston E, Wood D, Sweet RC, Hadley WK. Evaluation of PPLO, A7B, E and NYC agar media for the isolation of Ureaplasma urealyticum and Mycoplasma species from the genital tract. J Clin Microbiol 19: 73–76, 1984
  • Thomsen AC. The occurrence of mycoplasmas in the urinary tract of patients with chronic pyelonephritis. Acta Pathol Microbiol Scand Sect B 83: 10–16, 1975
  • Spaepen MS, Kundsin RB, Horne HW. Tetracycline-resistant T-Mycoplasmas (Ureaplasma urealyticum) from patients with history of retroproductive failure. Antimicrob Agents Chemother 9: 1012–1018, 1976
  • Shepard MC, Masover GK. Special features of ureaplasmas. Barile MF, Razin S, Tully JG, Whitcomb RF, eds. The Mycoplasmas. Academic Press, vol 1: 451–494, 1979
  • Black FT. Biological and physical properties of human T-Mycoplasmas. Ann NY Acad Sci 225: 131–143, 1973
  • McCormack WM, Almeida PC, Bailey PE, Grady EM, Lee YH. Sexual activity and vaginal colonization with genital mycoplasmas. JAMA 221: 1375–1377, 1972
  • Archer JF. “T” strain Mycoplasma in the female urogenital tract. Br J Vener Dis 44: 232–234, 1968

References

  • Nord CE, Heimdahl A, Kager L. Antimicrobial induced alterations of the human oropharyngeal and intestinal microflora. Scand J Infect Dis 49: 64–72, 1986
  • van der Waaij D. Colonisation resistance of the digestive tract: Clinical consequences and implications. J Antimicrob Chemother 10: 263–270, 1982
  • Hentges DJ, Stein AJ, Casey SW, Que JU. Protective role of intestinal flora against infection with Pseudomonas aeruginosa in mice: Influence of antibiotics on colonization resistance. Infect Immun 47: 118–122, 1985
  • Nord CE, Heimdahl A, Kager L, Malmborg AS. The impact of different antimicrobial agents on the normal gastrointestinal microflora of humans. Rev Infect Dis 6: S270–S275, 1984
  • Borthen L, Heimdahl A, Lindqvist L, Nord CE. Determination of volatile fatty acids in saliva and faeces by gas-liquid chromatography—a rapid method for detection of antibiotic-induced changes in the oropharyngeal and gastrointestinal microflora. Int J Microbiol 1: 35–45, 1983
  • Norrby SR. Ecological consequences of broad spectrum versus narrow spectrum antibacterial therapy. Scand J Infect Dis 49: 189–195, 1986
  • Alestig K, Lidin-Janson G. The effect of doxycycline and tetracycline hydrochloride on the aerobic fecal flora. Scand J Infect Dis 7: 265–271, 1975
  • Bartlett JG, Bustetter LA, Gorbach SL, Onderdonk A. Comparative effect of tetracycline and doxycycline on the occurrence of resistant Escherichia coli in the fecal flora. Antimicrob Agents Chemother 7: 55–60, 1975
  • Borglund E, Hägermark Ö, Nord CE. Impact of topical clindamycin and systemic tetracycline on the skin and colon microflora in patients with acne vulgaris. Scand J Infect Dis 43: 76–81, 1984
  • Aronsson B, Möllby R, Nord CE. Antimicrobial agents and Clostridium difficile in acute enteric disease: Epidemiological data from Sweden 1980–1982. J Infect Dis 151: 476–481, 1985

References

  • Baum ML, Anish DS, Chalmers TC, Sacks HS, Smith H, Fagerström RM. A survey of clinical trials of antibiotic prophylaxis in colon surgery: Evidence against further use of no-treatment controls. N Engl J Med 305: 795–799, 1981
  • Clarke JS, Condom RE, Bartlett JG. Preoperative oral antibiotics reduce septic complications of colon operations: Results of prospective randomized, double-blind clinical study. Ann Surg 185: 251–259, 1977
  • Washington JA, Dearing WH, Judd ES . Effect of preoperative antibiotic regimen on development of infection after intestinal surgery: Prospective randomized double-blind study. Ann Surg 180: 567–571, 1974
  • Finland M. Changing patterns on susceptibility of common bacterial pathogens to antimicrobial agents. Ann Intern Med 76: 1009–1036, 1972
  • Sabath LD. Drug resistance of bacteria. N Engl J Med 280: 91–94, 1969
  • Guerrant RL, Strausbaugh LJ, Wenzel RP, Hamory BH, Sande MA. Nosocomial bloodstream infections caused by gentamicin-resistant gram-negative bacilli. Am J Med 62: 894–901, 1977
  • Moellering RC, Wennersten C, Kunz LJ, Poitras JW. Resistance to gentamicin, tobramycin and amikacin among clinical isolates of bacteria. Am J Med 62: 873–881, 1977
  • Duncan IBR, Rennie RP, Duncan NH. A long-term study of gentamicin-resistant Pseudomonas aeruginosa in a general hospital. J Antimicrob Chemother 7: 147–155, 1981
  • Rollag H, Midtvedt T, Hovig B, Dahl O. Sensitivity patterns of bacteria and antibiotic usage at the national hospital of Norway in 1976 and 1978. Zentralbl Bakteriol 244: 515–524, 1979
  • Normark S. The development of antibiotic resistance in gram-negative bacteria. Läkartidningen 75: 3418–3420, 1978
  • Grassi GG. Clinical aspects of the relationship between antibiotic usage and resistance. J Antimicrob Chemother 3: 77–84, 1977
  • Ericsson HM, Sherris JC. Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol Microbiol Scand, Suppl 217, 1971
  • The Swedish reference group for antibiotics. A revised system for antibiotic sensitivity testing. Scand J Infect Dis 13: 148–152, 1981
  • Ode B, Forsgren A, Walder M. Sensitivity of 523 blood culture isolates to 33 antibiotics. Scand J Infect Dis 16: 61–71, 1984
  • Cowan ST, Steel KJ. Manual for the identification of medical bacteria. London: Cambridge University Press, 1970
  • Törnqvist A, Ekelund G, Forsgren A, Leandoer L, Olson S, Ursing J. Single dose doxycycline prophylaxis and peroperative bacteriological culture in elective colorectal surgery. Br J Surg 68: 565–568, 1981
  • Törnqvist A, Forsgren A, Leandoer L, Ursing J. Identification and antibiotic prophylaxis of high risk patients in elective colorectal surgery. World J Surgery 11: 115–119, 1987
  • Höjer H, Wetterfors J. Systemic prophylaxis with doxycycline in surgery of the colon and rectum. Ann Surg 187: 362–368, 1978
  • Wiedemann B. Development of resistance following the use of antibiotics. Scand J Gastroenterol Suppl 90: 21–27, 1984
  • Nord CE, Kager L, Heimdahl A. Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections. Am J Med, Suppl 76: 99–106, 1984
  • Chopra I, Howe TGB. Bacterial resistance to the tetracyclines. Microbiol Rev 42: 707–724, 1978
  • Alestig K, Lidin-Janson G. The effect of doxycycline and tetracycline hydrochloride on the aerobic fecal flora. Scand J Infect Dis 7: 265–271, 1975
  • Bartlett JG, Bustetter LA, Gorbach SL, Onderdonk AB. Comparative effect of tetracycline and doxycycline on the occurrence of resistant E. coli in the fecal flora. Antimicrob Agents Chemother 7: 55–57, 1975
  • Bergan T. Microbial spectrum and antimicrobial susceptibility in infections after gastrointestinal surgery. Scand J Gastroenterol, Suppl 90: 1–14, 1984
  • Davies J. General mechanisms of antimicrobial resistance. Rev Infect Dis 1: 23–27, 1979
  • Lindhagen J, Andåker L, Höjer H, Alm H, Nordlund S. Comparison of systemic prophylaxis with metronidazole/placebo and metronidazole/fosfomycin in colorectal surgery. Acta Chir Scand 150: 317, 1984
  • Huttunen R, Laitinen S, Mokka R, Ståhlberg M, Kairaluoma M, Herva E, Larmi T. Comparison of metronidazole with clindamycin-gentamycin combination in the prevention of infectious complications after elective colonic surgery. Ann Chir Gynecol 71: 317–320, 1982

References

  • Holmes KK, Eschenbach DA, Knapp JS. Salpingitis: Overview of etiology and epidemiology. Am J Obstet Gynecol 138: 893–900, 1980
  • Mårdh PA, Weström L. Tubal and cervical cultures in acute salpingitis with special reference to Myoplasma hominis and T-strain mycoplasmas. Br J Vener Dis 46: 179–186, 1970
  • Sweet RL. Pelvic inflammatory disease: Etiology, diagnosis and treatment. Sex Transm Dis 8, Suppl 308–315, 1981
  • Bergan T. Pharmacokinetics of tissue penetration of antibiotics. Rev Infect Dis 3: 45–66, 1981
  • Brihmer C, Brundin J, Dornbush K. Levels of Trimethroprim and Sulphamethoxazole in human oviduct mucosa and plasma. Acta Obstet Gynecol Scand 61: 149–152, 1982
  • Brihmer C, Brundin J. Levels of Ampicillin and Doxycycline in human oviduct mucosa and serum. Acta Obstet Gynecol Scand 62: 231–234, 1983
  • Ripa KT, Mårdh PA. Cultivation of Chlamydia trachomatis in cycloheximide treated McCoy cells. J Clin Microbiol 6: 328–331, 1977
  • Manual of Clinical Microbiology. 4th ed. Lemotte EH, ed.American Society for Microbiology, Washington DC, 1985
  • Jacobsson L, Weström L. Objectivized diagnosis of pelvic inflammatory disease. Am J Gynecol 105: 1088–1098, 1964
  • Ripa T, Forslin L, Danielsson D, Falk V. Frequency of gonococcal and chlamydial infections in patients with laparoscopically verified acute salpingitis in 1970 and 1980. Epidemiological considerations. In: Mårdh PA, Holmes KK, Oriel JD, Piot P, Schachter J, eds. Chlamydial infections. Elsevier Biomedical, 179–187, 1982
  • Weström L. Effect of acute pelvic inflammatory disease on fertility. Am J Obstet Gynecol 5: 707–713, 1975
  • Weström L. Sexually transmitted diseases. New York: McGraw Hill, 627–629, 1984
  • Falk V. Treatment of acute non-tuberculous salpingitis with antibiotics alone and in combination with glucocorticoids. Acta Obstet Gynecol Scand 44 ( Suppl 6): 3, 1965

References

  • Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983; 1: 1273–75
  • Goodwin CS, Armstrong JA, Marshall BJ. Campylobacter pyloridis, gastritis and peptic ulceration. J Clin Pathol 1986; 39: 353–65
  • Goodwin CS, Blake P, Blincow E. The minimum inhibitory and bactericidal concentration of antibiotic and antiulcer agents against Campylobacter pyloridis. Antimicrob Chemother 1986; 17: 309–14
  • McNulty CAM, Gearty JC, Crump B . Campylobacter pyloridis and associated gastritis; investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate. Br Med J 1986; 293: 645–49
  • Schaub N, Stalder GA, Affolter H, Wegmann W. Versagen von Doxycyclin bei Campylobacter-pylori-positiver Gastritis. Dtsch Med Wochenschr 1986; 112: 117–18
  • Morris A, Nicholson G. Ingestion of Campylobacter pyloridis causes gastritis and raised gastric pH. Am J Gastroenterol 1987; 82: 192–99
  • Goodwin CS, Blincow ED, Warren JR, Waters TE, Sanderson CR, Easton L. Evaluation of cultural techniques for isolating Campylobacter pyloridis from endoscopic biopsies of gastric mucosa. J Clin Pathol 1985; 38: 1127–31
  • Lambert T, Mégraud F, Gerbaud G, Courvalin P. Susceptibility of Campylobacter pyloridis to 20 antimicrobial agents. Antimicrob Agents Chemother 1986; 30: 510–11
  • Gnarpe H, Dornbusch K, Hägg O. Doxycycline concentration levels in bone, soft tissue and serum after intravenous infusion of doxycycline. Scand J Infect Dis Suppl 9, 1976; 54–57
  • Gnarpe H, Unge P, Blomqvist C. Enzyme immunoassay serology for primary screening of patients with Campylobacter pyloridis. Clin Immunol Newslett (in press).
  • Hirschl AM, Stanek G, Rotter ML . Campylobacter pyloridis: Frequency of occurrence, serology and susceptibility to antibiotics and ulcer-drugs. Abstr. 64, The IVth Intern. Workshop on Campylobacter Infections, June 16–18, 1987, Göteborg, Sweden

References

  • Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP. Lyme disease—a tick-borne spirochetosis? Science 216: 1316–1319, 1982
  • Steere AC, Grodzicki RL, Kornblatt AN. The spirochetal etiology of Lyme disease. N Engl J Med 308: 733–740, 1983
  • Afzelius A. Erythema chronicum migrans. Acta Derm Venereol (Stockh) 2: 120–125, 1921
  • Garin CH, Boujadoux C. Paralysie par les tiques. J Med Lyon 71: 765–767, 1922
  • Stiernstedt G, Granström M, Hederstedt B, Sköldenberg B. Diagnosis of spirochetal meningitis by enzyme-linked immunosorbent assay and indirect immunofluorescence assay in serum and cerebrospinal fluid. J Clin Microbiol 21: 819–825, 1985
  • Steere AC, Pachner AR, Malawista SE. Neurologic abnormalities of Lyme disease: Successful treatment with high-dose intravenous penicillin. Ann Intern Med 99: 767–817, 1983
  • Stiernstedt G. Tick-borne borrelia infection in Sweden. Scand J Infect Dis. 17: Suppl 45, 1985
  • Jalling B, Malmborg A-S, Lindman A, Boreus L-O. Evaluation of a micromethod for determination of antibiotic concentrations in plasma. Eur J Clin Pharmacol 4: 150–157, 1972
  • Hollström E. Successful treatment of erythema chronicum Afzelius. Acta Derm Venereol (Stockh) 31: 235–240, 1951
  • Hellerström S. Erythema chronicum migrans Afzelius with meningitis. Acta Derm Venereol (Stockh) 31: 227–234, 1951
  • Steere AC, Hutchinson GJ, Rahn DW, Sigal LH, Craft JE, De Sanna ET, Malawista SE. Treatment of the early manifestations of Lyme disease. Ann Intern Med 99: 22–26, 1983
  • Leibowitz BJ, Hakes JL, Cahn MM, Levy EJ. Doxycycline blood levels in normal subjects after intravenous and oral administration. Curr Ther Research 14: 820–826, 1972
  • Yim CW, Flynn NM, Fitzgerald FT. Penetration of oral doxycycline into the cerebrospinal fluid of patients with latent or neurosyphilis. Antimicrob Agents Chemother 28: 347–348, 1985
  • Johnson SE, Klein GC, Schmid GP, Feeley JC. Susceptibility to seven antimicrobial agents. Yale J Biol Med 57: 549–553, 1984
  • Andersson H, Alestig K. The penetration of doxycycline into CSF. Scand J Infect Dis. Suppl 9: 17–19, 1976
  • Hindfeldt B, Jeppsson PG, Nilsson B, Olsson JE, Ryberg B, Sörnäs R. Clinical and cerebrospinal fluid findings in lymphocyte meningo-radiculitis (Bannwarth's syndrome). Acta Neurol Scand 66: 444–453, 1982
  • Ackerman R, Hörstrup P, Schmidt R. Tick-borne meningopolyneuritis (Garin-Bujadoux, Bannwarth). Yale J Biol Med 57: 485–490, 1984
  • Kohler J, Kasper J, Kern U, Thoden U. Borrelia encephalomyelitis. Lancet i: 35, 1986
  • Bensch J, Olcén P, Hagberg L. Destructive chronic borrelia meningoencephalitis in a child untreated for 15 years. Scand J Infect Dis 19: 697–700, 1987
  • Klöter I, Adam T, Schabet M, Wiethölter H, Peiffer J. Borrelia-induced meningoradiculitis—two different forms of the disease. Eur Neurol 25: 262–268, 1986
  • Camponovo F, Meier C. Neuropathy of vasculitic origin in a case of Garin-Bujadoux-Bannwarth syndrome with positive borrelia antibody response. J Neurol 233: 69–72, 1986
  • Schmutzard E, Stanek G, Pohl P. Polyneuritis cranialis associated with Borrelia burgdorferi. J Neurol Neurosurg Psychiatry 48: 1182–1184, 1985
  • Barza M, Brown RB, Shanks C, Gamle C, Weinstein L. Relation between lipophilocity and pharmacological behaviour of minocycline, doxycycline, tetracycline and oxytetracycline in dogs. Antimicrob Agents Chemother 8: 713–730, 1975
  • Stiernstedt G, Sköldenberg BR, Vandvik B, Hederstedt B, Gårde A, Kolmodin G, Jörnbäck H, Svenungsson B. Chronic meningitis and Lyme disease in Sweden. Yale J Biol Med 57: 491–497, 1984

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.